GEN Exclusives

More »

GEN News Highlights

Back to Item »

Existing HIV Therapies Also Block Virus Associated with Prostate Cancer and Chronic Fatigue Syndrome

Merck & Co.’s Isentress was the most effective at blocking XMRV, according to a study in PLoS ONE.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Career Development Woes

What do you consider the greatest threat to your career prospects?

More »